Cinryze C1 inhibitor (human) 500UNITS/VIL INJ, pwdr emergency pharmaceutical
Ended Awarded
- Contract number
- 36C26124N0774
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $63,937
Award facts
- Contract value 100% obligated
- $63,936.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, MA 02421, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order awarded to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company Limited, for the supply of CINRYZE C1 Inhibitor (Human) 500 Units/Vial Injection under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The $63,936.90 order was placed by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21). The order has a completion date of July 31, 2024. No set-aside designation was used. Takeda Pharmaceuticals America Inc. is a global biopharmaceutical company that specializes in providing treatments for rare diseases, hematology, immunology, and oncology to U.S. government agencies, including the VA, Department of Justice Bureau of Prisons, and Department of Defense. This order supports the VA's critical patient care programs by ensuring access to CINRYZE, a treatment for hereditary angioedema.
Quick answers
Who was awarded contract 36C26124N0774?
36C26124N0774 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on July 15, 2024.
How much is contract 36C26124N0774 worth?
The government has obligated $63,937 on 36C26124N0774.
Is contract 36C26124N0774 an order under another contract?
Yes. 36C26124N0774 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0774 competed?
The extent of competition for 36C26124N0774 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award